International Comparisons

This document compares the US healthcare system with other developed nations to highlight structural differences.

Overall Cost Comparison

Healthcare Spending Per Capita (2023)

Country	Per Capita (USD)	% of GDP	System Type
United States	$12,555	17.3%	Private/mixed
Switzerland	$7,179	11.3%	Private (regulated)
Germany	$6,938	11.7%	Multi-payer
Norway	$6,813	10.5%	Public
Netherlands	$6,753	10.1%	Private (regulated)
Sweden	$6,262	10.9%	Public
Austria	$6,134	10.4%	Multi-payer
France	$5,564	11.3%	Public
Canada	$5,511	10.8%	Public
UK	$5,387	10.2%	Public (NHS)
Japan	$4,691	10.9%	Public
Spain	$3,600	9.1%	Public

Key insight: US spends 75-250% more per person than comparable wealthy nations.

Health Outcomes Comparison

Despite higher spending, US outcomes are often worse:

Metric	US	OECD Average
Life expectancy	76.4 years	80.3 years
Infant mortality	5.4 per 1,000	3.8 per 1,000
Maternal mortality	23.8 per 100k	8.4 per 100k
Preventable deaths	Higher	Lower

Conclusion: More spending ≠ better outcomes.

System Structure Comparison

United States

Payers: Hundreds of private insurers + Medicare + Medicaid
Price setting: Negotiated individually (hospitals have leverage)
Coverage: 91% insured (9% uninsured = 30M people)
Patient cost: High deductibles, copays, out-of-pocket
Barriers to entry: Very high
Competition: Limited (local monopolies)

United Kingdom (NHS)

Payer: Single (government)
Price setting: Centrally determined
Coverage: 100% automatic
Patient cost: £0 at point of service
Barriers to entry: Hospitals are public
Competition: Quality competition (same prices)

Germany

Payers: ~100 non-profit "sickness funds"
Price setting: Negotiated nationally (unified rates)
Coverage: 100% (mandatory insurance)
Patient cost: Low copays
Barriers to entry: Moderate (must join rate system)
Competition: Quality competition (regulated prices)

Switzerland

Payers: Multiple private insurers
Price setting: Regulated (government sets reference prices)
Coverage: 100% (mandatory insurance)
Patient cost: Moderate copays
Barriers to entry: Moderate (must accept reference prices)
Competition: Service quality, network, supplemental insurance

France

Payer: Public + supplemental private
Price setting: Government sets rates
Coverage: 100%
Patient cost: Low (public covers 70%, supplemental covers rest)
Barriers to entry: Low (standardized prices)
Competition: Quality and service

Key Structural Differences

1. Price Setting

Country	Method	Hospital Leverage
US	Individual negotiation	Very high
UK	Government sets	None
Germany	National negotiation	Low
Switzerland	Reference pricing	Low
France	Government sets	None
Canada	Provincial government sets	None

US is unique: Hospitals negotiate individually and have monopoly power.

2. Universal Coverage

Country	% Covered	Uninsured Population
UK, France, Spain, etc.	100%	0
Germany	100%	0
Switzerland	100%	0
US	91%	30 million

US is unique: Only developed nation without universal coverage.

3. Administrative Costs

Country	Admin % of Total Healthcare Spending
US	25-30%
Canada	12-17%
France	5-8%
UK	5-6%
Germany	6-8%

Why US is higher: - Hundreds of different insurers with different rules - Complex billing (thousands of codes) - Prior authorization bureaucracy - Eligibility verification for each patient - Claims disputes and appeals

4. Pharmaceutical Costs

Country	Method	Price vs US
US	Market pricing (no negotiation)	Baseline (highest)
UK	Government negotiates	40-60% cheaper
Germany	Reference pricing + negotiation	30-50% cheaper
France	Government negotiates	40-70% cheaper
Canada	Bulk purchasing	30-50% cheaper

Example: Insulin - US: $300-500/month - Canada: $30-50/month - UK: Free (NHS covers)

5. Medical Education Costs

Country	Medical School Cost	Student Debt
US	$200k-300k	$200k-300k average
Germany	Free	€0
France	~€500/year	Minimal
UK	~£9,000/year	£30k-40k
Spain	~€1,000/year	Minimal
Sweden	Free	€0

Impact: US doctors need higher salaries to repay debt.

6. Malpractice Environment

Country	Culture	Physician Insurance Cost
US	Litigious	$50k-250k/year
UK	Less litigious	£5k-15k/year
Germany	Less litigious	€5k-15k/year
France	Less litigious	€3k-10k/year

Impact: US defensive medicine adds ~$50-100B/year in unnecessary tests.

How Other Countries Avoid the US Problems

Problem: Hospital Monopoly Power

How others solve: - Single payer (UK, Canada, Spain): Government has monopsony power - Regulated pricing (Germany, France): Hospitals cannot set own prices - All-payer system (Maryland in US): Same rates for all insurers

Problem: Insurer Perverse Incentives

How others solve: - Non-profit insurers (Germany): Sickness funds don't maximize profit - Single payer (UK, Canada): No insurance company middleman - Fixed budgets (France): Hospitals get global budgets, not fee-for-service

Problem: Entry Barriers

How others solve: - Standardized pricing: New hospitals face same prices as old ones - Public hospitals: Government builds where needed - Lower labor costs: Cheaper education, easier immigration

Problem: Price Opacity

How others solve: - Published prices: Rates are public and standardized - Free at point of service: Patient doesn't see bill at all - Reference pricing: Insurance pays fixed amount, patient knows in advance

Problem: Geographic Captivity

How others solve: - This problem exists everywhere (emergencies are local) - But: Standardized pricing means geographic monopoly can't exploit it - Patients can't shop during emergency, but prices are fixed anyway

Why Can't US Copy Them?

Political Barriers

Powerful vested interests:
Hospital systems with billions in revenue
Insurance companies with billions in revenue
Pharmaceutical companies with billions in revenue
All lobby heavily against change
Ideological opposition:
"Socialism" label on public healthcare
Fear of government control
Distrust of centralized systems
Path dependence:
Employer-based system deeply embedded
Millions of jobs in health insurance industry
Existing contracts and infrastructure
Hard to transition without disruption

Technical Barriers

Fragmentation:
50 state systems with different rules
Federal system makes national policy difficult
Would need constitutional changes for single-payer
Existing commitments:
Medicare/Medicaid already cover 40% of population
Can't easily merge private and public systems
Transition costs would be enormous

Economic Barriers

Healthcare is 17% of GDP:
Cutting prices means cutting someone's income
Would eliminate millions of administrative jobs
Painful economic adjustment
Debt overhang:
Doctors have $200k-300k debt
Can't cut salaries without debt relief
Would require massive financial intervention

Success Stories: Countries That Reformed

Taiwan (1995)

Before: Fragmented system, 40% uninsured, high costs Reform: Implemented single-payer National Health Insurance Result: - 100% coverage - Lower costs - Better outcomes - 90% public satisfaction

Key factor: Reformed before system became too entrenched.

Australia (1984)

Before: Mixed system with gaps Reform: Implemented Medicare (public insurance) Result: - Universal coverage - Lower costs than US - Dual public/private system works well

Key factor: Strong political mandate + gradual implementation.

Closest US Comparison: Medicare

Medicare (for seniors 65+): - Functions like single-payer for elderly - Lower administrative costs than private insurance - Negotiates prices (somewhat) - Outcomes similar or better than private insurance - Satisfaction rates >80%

Limitations: - Only covers seniors - Limited negotiating power (by law, cannot negotiate drug prices strongly) - Still operates within high-cost US system

"Medicare for All" proposal: Extend Medicare to everyone.

Summary Table: Why US is Different

Factor	US	Other Developed Nations
Price setting	Negotiated (hospital leverage)	Regulated/standardized
Number of payers	Hundreds	1-100
Universal coverage	❌ No	✅ Yes
Admin costs	25-30%	5-12%
Medical school	Very expensive	Free or cheap
Malpractice	High litigation	Lower litigation
Immigration (healthcare workers)	Restricted	Easier (EU internal)
Drug price negotiation	Minimal	Strong
Hospital entry barriers	Very high	Moderate

Conclusion: US system is structurally unique in ways that drive costs up.